Axa’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-182,356
Closed -$14.2M 1429
2016
Q2
$14.2M Sell
182,356
-1,706,024
-90% -$122M 0.06% 310
2016
Q1
$104M Buy
1,888,380
+370,895
+24% +$20.2M 0.47% 49
2015
Q4
$93.7M Buy
1,517,485
+721,147
+91% +$45.5M 0.41% 55
2015
Q3
$50.2M Buy
796,338
+406,406
+104% +$29M 0.21% 134
2015
Q2
$28.5M Buy
389,932
+104,958
+37% +$7.58M 0.11% 205
2015
Q1
$18.6M Sell
284,974
-304,424
-52% -$20.2M 0.08% 273
2014
Q4
$38.3M Buy
589,398
+180,420
+44% +$11.6M 0.15% 175
2014
Q3
$24.6M Buy
408,978
+76,017
+23% +$4.97M 0.11% 225
2014
Q2
$23.1M Sell
332,961
-47,735
-13% -$3.09M 0.1% 238
2014
Q1
$24.9M Sell
380,696
-108,121
-22% -$7.04M 0.11% 217
2013
Q4
$30.3M Buy
488,817
+136,495
+39% +$7.9M 0.14% 185
2013
Q3
$18.9M Sell
352,322
-139,996
-28% -$7.21M 0.09% 241
2013
Q2
$22.5M Buy
+492,318
New +$21.3M 0.12% 194

Other funds holding STJ

Axa's STJ Position: Q3 2016 in Review

Axa sold out of St Jude Medical (STJ) in Q3 2016, closing a stake of 182,356 shares — an estimated $14.2M sold.

Axa first reported a position in STJ in Q2 2013 and held it in 13 quarters. The position peaked at $104M in Q1 2016. 570 funds tracked by Wall St. Rank hold STJ as of Q3 2016.

  • Axa reported no remaining St Jude Medical position as of Q3 2016 after selling out during the quarter.
  • Axa sold 182,356 St Jude Medical shares in Q3 2016, an estimated $14.2M.
  • Axa first reported a position in St Jude Medical in Q2 2013 and held it in 13 quarters.
  • Axa's St Jude Medical position peaked at $104M in Q1 2016.
  • 570 funds tracked by Wall St. Rank held St Jude Medical as of Q3 2016.

Based on Axa's 13F filing for Q3 2016, filed 10 Nov 2016.